9th Annual IBDHorizons Pacific Northwest Symposium
IBDHorizons is pleased to announce the 9th Annual IBD-focused Pacific Northwest Symposium, in Seattle
IBDHorizons provides free IBD conferences open to all those who treat or interested in treating patients with IBD.
At our 9th Annual Pacific Northwest IBD conference, you will learn from and engage in discourse about the latest in Inflammatory Bowel Disease (IBD) from world-renowned faculty, on Saturday, March 9, 2024.
During the IBDHorizons Pacific Northwest Symposium, you’ll be provided with a smooth experience including catered meals, thoughtful breaks throughout the day’s events, and a personal tablet to engage with the presentations. We dedicate more time than most other IBD conferences to our open panel discussions and real-world case studies to be examined alongside the faculty.
Our Pacific Northwest IBD conference will be hosted at the Embassy Suites by Hilton in Pioneer Square, 255 S. King Street, Seattle, WA.
Speakers and topics will be announced! As always, our IBD Founders and honorary board members Dr. Brian Feagan and Dr. Feza Remzi will be speaking.
This IBDHorizons event is expected to be accredited for up to 6 CME, CE, and CPE credit hours for attendees.
Registration is required to plan accordingly, but registration for IBDHorizons Pacific Northwest is complimentary to attendees!
IBDHorizons IBD-dedicated conference presents an excellent opportunity for industry exhibits. Please contact us for more information.
Ultrasound & Endoscopy Lab
IBDHorizons continues its live hands-on ultrasound and endoscopy lab session. Live lab session includes demonstrations and hands-on format allowing participants to review and try the newest endoscopic technology including:
- Intestinal Ultrasound (IUS) for IBD
- Full thickness resection devices
- Endoscopic submucosal dissection
- Virtual chromo-endoscopy
- Standard endoscopic devices and technology
If you have register for the in-person Pacific Northwest symposium, you will automatically be registered for this session.
Research Plenary Session
Returning this year is our Abstract presentations and Research Plenary Session. The deadline for submission of abstracts is February 17, 2024.
Join us for this amazing IBD conference opportunity to engage with notable leaders in the field of Inflammatory Bowel Disease (IBD).
Anita Afzali, MD, MPH, MHCM Professor of Medicine in the Division of Digestive Diseases, Executive Vice Chair of Medicine in the Department of Internal Medicine at the University of Cincinnati College of Medicine, Associate Chief Medical Officer of the UC Health SystemAnita Afzali, MD, MPH, MHCMProfessor of Medicine in the Division of Digestive Diseases, Executive Vice Chair of Medicine in the Department of Internal Medicine at the University of Cincinnati College of Medicine, Associate Chief Medical Officer of the UC Health System
Dr. Anita Afzali is a Professor of Medicine in the Division of Digestive Diseases and Executive Vice Chair of Medicine in the Department of Internal Medicine at the University of Cincinnati College of Medicine. She is also the Associate Chief Medical Officer of the UC Health System. She received her medical degree and then completed Internal Medicine residency and gastroenterology fellowship at the University of Washington in Seattle, WA. While in fellowship, Dr. Afzali worked in outcomes research and epidemiology, and graduated with a Masters in Public Health from The University of Washington. She then later obtained another Masters In Healthcare Management (MHCM) from Harvard T.H. Chan School of Public Health. Her sub-specialty training includes a one-year advanced IBD fellowship at the University of Washington, prior to becoming faculty.
While practicing at the University of Washington – Harborview Medical Center, Dr. Afzali served as the Director of the IBD Program and Associate Medical Director of Gastroenterology Clinics. After Seattle, Dr. Afzali moved to Columbus, OH to be the Medical Director of The OSU IBD Center and the Vice Chair of Clinical Operations of Gastroenterology at The Ohio State University.
Recently, she has transitioned to the University of Cincinnati where she serves as the Executive Vice Chair of the Department of Internal Medicine. Her research interests include drug study design, investigational drug trials, and clinical outcomes. She has extensive peer-reviewed publications, an invited lecturer on national and international programs, and serves on several international advisory boards and committees including Chair of the American College of Gastroenterology (ACG) Educational Affairs Committee and Vice Chair of Publications Committee for the World Gastroenterology Organization (WGO).
Brian Feagan, MD, MSc Professor of Medicine at the Schulich School of Medicine & Dentistry in London, Ontario, Senior Scientific Director of Alimentiv IncBrian Feagan, MD, MScProfessor of Medicine at the Schulich School of Medicine & Dentistry in London, Ontario, Senior Scientific Director of Alimentiv Inc
Dr. Brian Feagan is a gastroenterologist, with training in Clinical Epidemiology and Biostatistics. His research focus is the design, conduct, and execution of large-scale randomized controlled trials (RCTs) in Crohn’s disease (CD) and ulcerative colitis (UC), and over the past 30 years, has been Principal Investigator in over 140 multi-center RCTs. His research has been devoted to the development, validation, and optimization of outcome measures to assess the efficacy of novel therapeutics in CD and UC. Dr. Feagan is Professor of Medicine at the Schulich School of Medicine & Dentistry, a gastroenterologist at London Health Sciences Centre and Senior Scientific Director of Alimentiv Inc (formerly Robarts Clinical Trials Inc).
Brian G. Feagan completed a medical degree at the University of Western Ontario in London, Ontario, Canada. His postdoctoral training included a residency in the Department of Medicine and a fellowship in Gastroenterology at the University of Western Ontario. A Fellow of the Royal College of Physicians and Surgeons of Canada, Dr. Feagan holds membership in the Canadian and American Association of Gastroenterology, the American College of Gastroenterology, the College of Physicians and Surgeons of Ontario, Crohn’s and Colitis Canada (CCC), and the European Crohn’s & Colitis Organization (ECCO). He is the recipient of the 2013 Senior Achievement Award from the Crohn’s & Colitis Foundation of America (CCF) and the Dean’s Award of Excellence in 2013 from the University of Western Ontario. He has authored over 200 articles, book chapters and has also given over 900 invited presentations, at national and international scientific meetings. In 1997, Dr. Feagan became Director of Robarts Clinical Trials (now Alimentiv, Inc.).
David Hudesman, MD Co-Director at IBD Center NYU Langone Health; Professor of Medicine at NYU School of MedicineDavid Hudesman, MDCo-Director at IBD Center NYU Langone Health; Professor of Medicine at NYU School of Medicine
Dr. Hudesman is Co-Director of the Inflammatory Bowel Disease Center at NYU Langone Health. He is Professor of Medicine at the NYU School of Medicine.
Dr. Hudesman specializes in the diagnosis and treatment of inflammatory bowel disease (IBD) and in the provision of integrated, seamless, patient-centered care. His research is focused on the development of biomarkers and evaluation and optimization of new medical therapies for the treatment of both Crohn’s disease and ulcerative colitis.
Dr. Hudesman served on the Research Committee and is currently a member of the Educational Affairs Committee of the American College of Gastroenterology (ACG), the Professional Membership Committee of the Crohn’s Colitis Foundation (CCF), and the Quality Committee of the American Gastroenterological Association (AGA). He is a reviewer for many scientific gastroenterology journals and is on the editorial board of the IBD Journal.
Feza Remzi, MD Vice President and Colorectal Surgeon at Northwell Health Center for Advanced IBD Care, New YorkFeza Remzi, MDVice President and Colorectal Surgeon at Northwell Health Center for Advanced IBD Care, New York
Dr. Feza Remzi is the Vice President and a colorectal surgeon at the Center for Advanced IBD Care at Northwell Health in New York.
He is a national and international expert in colorectal surgery, specializing in the surgical management of inflammatory bowel disease (IBD). He performs pelvic pouch surgery, complex abdominopelvic re-operative surgery, and sphincter-saving surgery for rectal cancer, utilizing minimally invasive techniques to manage colorectal conditions.
Dr. Remzi resides in New York with his wife and son. They enjoy traveling and spending time together as a family.
Dr. Remzi is an honorary IBDHorizons Board member.
Ghassan Wahbeh, MD Director of the Inflammatory Bowel Disease (IBD) Center at Seattle Children’s Hospital. Professor of Pediatrics and Gastroenterology at the University of Washington School of Medicine and Director of Clinical Gastroenterology Operations.Ghassan Wahbeh, MDDirector of the Inflammatory Bowel Disease (IBD) Center at Seattle Children’s Hospital. Professor of Pediatrics and Gastroenterology at the University of Washington School of Medicine and Director of Clinical Gastroenterology Operations.
Ghassan Wahbeh, MD, is the Director of the Inflammatory Bowel Disease (IBD) Center at Seattle Children’s Hospital. He is a Professor of Pediatrics and Gastroenterology at the University of Washington School of Medicine and Director of Clinical Gastroenterology Operations. Dr. Wahbeh’s clinical focus is in advanced care for children, adolescents, and young adults with Crohn’s Disease and ulcerative colitis, including advanced therapeutics and perioperative IBD management. He leads the Intestinal Ultrasound Program at Seattle Children’s.
Dr. Wahbeh’s research interests include novel therapeutics for pediatric IBD, advanced disease monitoring towards mucosal healing, clinical standard work in managing severe colitis and complicated Crohn’s disease including fistulizing and stricturing phenotypes, and navigating IBD surgical options. He is actively involved in translational IBD research at Seattle Children’s Hospital. Dr. Wahbeh is actively involved as teaching faculty in medical student education, resident training and fellow physician specialty, and advanced IBD specialty training.
He is the honored recipient of the Outstanding Teaching Faculty Award, as well as the Family Choice Award, and the Northwest Crohn’s & Colitis Foundation service award. Dr. Wahbeh enjoys playing soccer, skiing, and paddle-boarding with his wife and kids.
Dr. Ghassan Wahbeh is a co-founder of IBDHorizons
Maia Kayal, MD Assistant Professor in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai and The Susan and Leonard Feinstein Inflammatory Bowel Disease (IBD) CenterMaia Kayal, MDAssistant Professor in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai and The Susan and Leonard Feinstein Inflammatory Bowel Disease (IBD) Center
Assistant Professor in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai and The Susan and Leonard Feinstein Inflammatory Bowel Disease (IBD) Center. She specializes in the care of patients with IBD and research in inflammatory conditions of the ileal pouch.
Scott D. Lee, MD Associate Professor of Medicine, Director, Clinical Inflammatory Bowel Disease Program at University of Washington Medical CenterScott D. Lee, MDAssociate Professor of Medicine, Director, Clinical Inflammatory Bowel Disease Program at University of Washington Medical Center
Dr. Scott D. Lee is an Associate Professor of Medicine with expertise in inflammatory bowel disease (Crohn’s disease and ulcerative colitis). Dr. Lee earned his bachelor’s degree at Pomona College and his M.D. at Jefferson Medical College. He completed his residency in internal medicine at the University of Colorado in Denver. After residency, Dr. Lee completed his gastroenterology fellowship at the University of Washington. After completing his fellowship, he attended the University of Chicago and Cedar-Sinai in Los Angeles as a visiting physician to gain additional training in IBD. Since finishing his fellowship, he has been an attending gastroenterology physician at the University of Washington Medical Center. Currently, his clinical practice is at the Digestive Disease Center at the University of Washington and is dedicated exclusively to providing care to patients with the diagnosis of IBD. His research is focused on inflammatory bowel diseases (IBD) including – new therapies for IBD, improving outcomes in the treatment and long-term management of IBD, evaluation of non-invasive biomarkers to assess disease activity in IBD patients, and the effects of the microbiome on IBD. He has participated in more than 100 clinical trials in IBD and continues to have an active clinical research program. He is a member of the Crohn’s Colitis Foundation of America (CCF), American Gastroenterology Association, American College of Gastroenterology, and American Society of Gastrointestinal Endoscopy. He is a past chair of Northwest CCFA Chapter Medical Advisory Committee (CMAC) and continues as a current member of the CMAC.
Tina Ha, MDDirector, Inflammatory Bowel Diseases Section, Mayo Clinic Arizona
Dr. Tina Ha is a gastroenterologist in Scottsdale, Arizona. She is affiliated with multiple hospitals, including Mayo Clinic- Phoenix, where she is the Director of the Inflammatory Bowel Diseases Section, and Cedars-Sinai Medical Center.
Dr. Ha earned her medical degree from the Albert Einstein College of Medicine of Yeshiva University. She did an internal medicine residency at Washington University in St. Louis School of Medicine as well as a fellowship in gastroenterology. She continued to a fellowship in inflammatory bowel disease at the Icahn School of Medicine at Mount Sinai.
She likes to spend her free time exploring with her golden retriever Sebastian, – who does not enjoy walking or retrieving, friends and family.
Dr. Ha has contributed to many publications on the topic of IBD.